Darkjade Sciences – Starlight International Science and Technology (Beijing)
1 Fairs
Email:
wxm@darkjades.com
🔒 Premium
About
Product overview
DarkJade Sciences is a biomedical research enterprise with organoid science at its core. We have a research and development center for smart organoid equipment and chips, an organoid-based precision medical testing laboratory, an international drug discovery and development platform, and a biobank of human-derived organoids. Our leading scientists come from the world's leading biomedical teams, such as Harvard University and the Massachusetts Institute of Technology. We have established precision medicine laboratories with market, clinical and academic research resources across the country. We have also established a joint organoid R&D center with Huazhong University of Science and Technology. Our main products include intelligent organoid equipment, organoid microchips and reagent kits, clinical trial and drug R&D services, organoid database and artificial intelligence software systems. We comprehensively create a business platform for intelligent organoid equipment, chips and biomedical technologies. Organoid technology allows for the creation of highly efficient and low-cost disease models, providing an effective platform for reflecting drug sensitivity of lesions and preventing the risks of developing drug resistance and targeted drug resistance in tumors or other phenotypic diseases encountered during drug testing in patients. This brings significant benefits to patients in terms of treatment regimens and life extension. It also greatly improves efficiency and preserves heterogeneity in the research and development of new drugs. Our team is deeply involved in core organoid technologies, having achieved standardization and automation in living lesion tissue culture and drug delivery operations. Having mastered the latest international technologies, our team has developed the most effective clinical testing services, bringing enormous benefits to cancer patients. DarkJade Sciences is a research-oriented biomedical enterprise with organoid science as our core technology. We have an organoid intelligent equipment and chip R&D center, an organoid precision medical testing laboratory, an international new drug R&D platform, and a human-derived organoid biobank. Our core scientific researchers come from world-class biomedical teams such as Harvard University and MIT. We have established precision medical laboratories with market, clinical, and scientific research resources across the country. We have also established a joint organoid R&D center with Huazhong University of Science and Technology. Our core products cover organoid intelligent equipment, organoid microchips and reagent kits, clinical testing and drug R&D services, organoid database, and AI application software systems. We are comprehensively building a business application platform for organoid intelligent equipment, chips, and biomedical technologies. Organoid technology enables the establishment of disease models with high-efficiency and low-cost , which is an effective platform to reflect the sensitivity of lesions to drugs and avoid the risks of drug resistance and targeted drug resistance in tumor or other phenotypic diseases caused by drug testing on patients, bringing significant benefits to patients in terms of medication regimens and prolongation of survival. It also greatly improves the efficiency and heterogeneity retention in the field of new drug research and development. Our team has been deeply engaged in the underlying technology of organoids, achieving standardization and automation in the cultivation of live lesion tissues and drug interven tion operations. By mastering internationally advanced core technologies, our team has developed ultimate efficiency in clinical testing services, bringing great benefits to cancer - patients. 【黑玉科学】试剂盒-俄语.pdf
【黑玉科学】芯片-俄语.pdf
【黑玉科学】药敏-俄语.pdf
DarkJade Sciences is a biomedical research enterprise with organoid science at its core. We have a research and development center for smart organoid equipment and chips, an organoid-based precision medical testing laboratory, an international drug discovery and development platform, and a biobank of human-derived organoids. Our leading scientists come from the world's leading biomedical teams, such as Harvard University and the Massachusetts Institute of Technology. We have established precision medicine laboratories with market, clinical and academic research resources across the country. We have also established a joint organoid R&D center with Huazhong University of Science and Technology. Our main products include intelligent organoid equipment, organoid microchips and reagent kits, clinical trial and drug R&D services, organoid database and artificial intelligence software systems. We comprehensively create a business platform for intelligent organoid equipment, chips and biomedical technologies. Organoid technology allows for the creation of highly efficient and low-cost disease models, providing an effective platform for reflecting drug sensitivity of lesions and preventing the risks of developing drug resistance and targeted drug resistance in tumors or other phenotypic diseases encountered during drug testing in patients. This brings significant benefits to patients in terms of treatment regimens and life extension. It also greatly improves efficiency and preserves heterogeneity in the research and development of new drugs. Our team is deeply involved in core organoid technologies, having achieved standardization and automation in living lesion tissue culture and drug delivery operations. Having mastered the latest international technologies, our team has developed the most effective clinical testing services, bringing enormous benefits to cancer patients. DarkJade Sciences is a research-oriented biomedical enterprise with organoid science as our core technology. We have an organoid intelligent equipment and chip R&D center, an organoid precision medical testing laboratory, an international new drug R&D platform, and a human-derived organoid biobank. Our core scientific researchers come from world-class biomedical teams such as Harvard University and MIT. We have established precision medical laboratories with market, clinical, and scientific research resources across the country. We have also established a joint organoid R&D center with Huazhong University of Science and Technology. Our core products cover organoid intelligent equipment, organoid microchips and reagent kits, clinical testing and drug R&D services, organoid database, and AI application software systems. We are comprehensively building a business application platform for organoid intelligent equipment, chips, and biomedical technologies. Organoid technology enables the establishment of disease models with high-efficiency and low-cost , which is an effective platform to reflect the sensitivity of lesions to drugs and avoid the risks of drug resistance and targeted drug resistance in tumor or other phenotypic diseases caused by drug testing on patients, bringing significant benefits to patients in terms of medication regimens and prolongation of survival. It also greatly improves the efficiency and heterogeneity retention in the field of new drug research and development. Our team has been deeply engaged in the underlying technology of organoids, achieving standardization and automation in the cultivation of live lesion tissues and drug interven tion operations. By mastering internationally advanced core technologies, our team has developed ultimate efficiency in clinical testing services, bringing great benefits to cancer - patients. 【黑玉科学】试剂盒-俄语.pdf
【黑玉科学】芯片-俄语.pdf
【黑玉科学】药敏-俄语.pdf
Fair Participations
BelarusMedica
01.04.2027 - 01.04.2027 · Minsk, Belarus
Booth: F7-F10, F22
